PropertyValue
?:abstract
  • The heterogeneous disease course of COVID-19 is unpredictable, ranging from mild self-limiting symptoms to cytokine storms, acute respiratory distress syndrome (ARDS), multi-organ failure and death. Identification of high-risk cases will enable appropriate intervention and escalation. This study investigates the routine laboratory tests and cytokines implicated in COVID-19 for their potential application as biomarkers of disease severity, respiratory failure and need of higher-level care. From analysis of 203 samples, CRP, IL-6, IL-10 and LDH were most strongly correlated with the WHO ordinal scale of illness severity, the fraction of inspired oxygen delivery, radiological evidence of ARDS and level of respiratory support (p ≤ 0.001). IL-6 levels of ≥3.27 pg/ml provide a sensitivity of 0.87 and specificity of 0.64 for a requirement of ventilation, and a CRP of ≥37 mg/L of 0.91 and 0.66. Reliable stratification of high-risk cases has significant implications on patient triage, resource management and potentially the initiation of novel therapies in severe patients.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.clim.2020.108614
?:doi
?:journal
  • Clin_Immunol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/bce4b08b1a4528c865d6e59664b6c764ffe9ad39.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7581344.xml.json
?:pmcid
?:pmid
?:pmid
  • 33153974.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Laboratory biomarkers associated with COVID-19 severity and management
?:type
?:year
  • 2020-10-22

Metadata

Anon_0  
expand all